Lv1
5 积分 2021-01-11 加入
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
2小时前
待确认
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
2小时前
已完结
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
27天前
已完结
Toward Ablative SBRT for Nonmetastatic PDAC
2个月前
已完结
Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials
3个月前
已完结
Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma
7个月前
已完结
The role of chemotherapy in the management of pancreatic acinar cell carcinoma
7个月前
已完结
Prophylactic Extended-Field Irradiation Versus Pelvic Irradiation in Patients With Cervical Cancer With 2018 FIGO Stage IIIC1 Disease
7个月前
已完结
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
8个月前
已完结
Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study
8个月前
已完结
皖公网安备34019202002308
